FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Gagneja Sumeet 2. Issuer Name and Ticker or Trading Symbol XILINX INC [ XLNX ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
CVP & Principal Acct Officer
(Last)         (First)         (Middle)
2100 LOGIC DR
3. Date of Earliest Transaction (MM/DD/YYYY)
12/10/2020
(Street)
SAN JOSE, CA 95124
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
XLNX COMMON STOCK  12/10/2020    M    650 (1) A $0  2068  D   
XLNX COMMON STOCK  12/10/2020    F    225  D $143.86  1843  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit  $0  12/10/2020    M        650   12/10/2020  12/10/2023 (2) XLNX COMMON STOCK  650  $0 (1) 1951  D   

Explanation of Responses:
(1)  Each restricted stock unit represents a contingent right to receive one share of XLNX common stock upon vesting of the unit.
(2)  Subject to the continued employment of the reporting person through the applicable vesting date, the restricted stock units will vest in equal installments and be settled on each of the first four anniversaries of the date of grant through the expiration date indicated. Date Exercisable refers to the initial grant vesting date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Gagneja Sumeet
2100 LOGIC DR
SAN JOSE, CA 95124


CVP & Principal Acct Officer

Signatures
/s/ Steven C. Madrigal, Attorney-in-fact for Sumeet Gagneja 12/10/2020
**Signature of Reporting Person Date